Cancer stem cell–immune cell crosstalk in tumour progression
Open accessThe DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Abstract
Cellular heterogeneity and an immunosuppressive tumour microenvironment are independent yet synergistic drivers of tumour progression and underlie therapeutic resistance. Recent studies have highlighted the complex interaction between these cell-intrinsic and cell-extrinsic mechanisms. The reciprocal communication between cancer stem cells (CSCs) and infiltrating immune cell populations in the tumour microenvironment is a paradigm for these interactions. In this Perspective, we discuss the signalling programmes that simultaneously induce CSCs and reprogramme the immune response to facilitate tumour immune evasion, metastasis and recurrence. We further highlight biological factors that can impact the nature of CSC–immune cell communication. Finally, we discuss targeting opportunities for simultaneous regulation of the CSC niche and immunosurveillance. This Perspective discusses the signalling programmes and biological factors that simultaneously induce cancer stem cells and reprogramme the immune response to facilitate tumour immune evasion. It also highlights therapeutic opportunities for simultaneous targeting of the cancer stem cell niche and immunosurveillance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Body Fatness and Cancer — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
The Tumor Microenvironment Innately Modulates Cancer Progression
Hinshaw, D. C., & Shevde, L. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3962 · Cited by 3,270
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.-L., Luke, J. J., & Gajewski, T. F. (2018) · Science · doi:10.1126/science.aao3290 · Cited by 3,107
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Batlle, E., & Clevers, H. (2017) · Nature Medicine · doi:10.1038/nm.4409 · Cited by 2,769
Hashimoto, D., Chow, A., Noizat, C., Teo, P., Beasley, M. B., Leboeuf, M., Becker, C. D., See, P., Price, J., Lucas, D., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.004 · Cited by 2,311
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Davies, L. C., Jenkins, S. J., Allen, J. E., & Taylor, P. R. (2013) · Nature Immunology · doi:10.1038/ni.2705 · Cited by 2,096
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Veglia, F., Sanseviero, E., & Gabrilovich, D. I. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00490-y · Cited by 1,940
Tissue-Resident Macrophage Ontogeny and Homeostasis
Ginhoux, F., & Guilliams, M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.024 · Cited by 1,884
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Riquelme, E., Zhang, Y., Zhang, L., Montiel, M., Zoltan, M., Dong, W., Quesada, P., Sahin, I., Chandra, V., San Lucas, A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.008 · Cited by 1,577
Cancer stem cells in glioblastoma
Lathia, J. D., Mack, S. C., Mulkearns-Hubert, E. E., Valentim, C. L. L., & Rich, J. N. (2015) · Genes & Development · doi:10.1101/gad.261982.115 · Cited by 1,520
Self-citationMicrobiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Mager, L. F., Burkhard, R., Pett, N., Cooke, N. C. A., Brown, K., Ramay, H., Paik, S., Stagg, J., Groves, R. A., Gallo, M., et al. (2020) · Science · doi:10.1126/science.abc3421 · Cited by 1,407
Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration
Lindemans, C. A., Calafiore, M., Mertelsmann, A. M., O’Connor, M. H., Dudakov, J. A., Jenq, R. R., Velardi, E., Young, L. F., Smith, O. M., Lawrence, G., et al. (2015) · Nature · doi:10.1038/nature16460 · Cited by 1,109
Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity
Mitroulis, I., Ruppova, K., Wang, B., Chen, L.-S., Grzybek, M., Grinenko, T., Eugster, A., Troullinaki, M., Palladini, A., Kourtzelis, I., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.034 · Cited by 1,100
Targeting STAT3 in Cancer Immunotherapy
Zou, S., Tong, Q., Liu, B., Huang, W., Tian, Y., & Fu, X. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01258-7 · Cited by 1,050
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
Cannarile, M. A., Weisser, M., Jacob, W., Jegg, A.-M., Ries, C. H., & Rüttinger, D. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0257-y · Cited by 1,020
Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age
Pang, W. W., Price, E. A., Sahoo, D., Beerman, I., Maloney, W. J., Rossi, D. J., Schrier, S. L., & Weissman, I. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116110108 · Cited by 991
Mitchem, J. B., Brennan, D. J., Knolhoff, B. L., Belt, B. A., Zhu, Y., Sanford, D. E., Belaygorod, L., Carpenter, D., Collins, L., Piwnica-Worms, D., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2731 · Cited by 943
Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3090 · Cited by 940
Cassetta, L., Fragkogianni, S., Sims, A. H., Swierczak, A., Forrester, L. M., Zhang, H., Soong, D. Y. H., Cotechini, T., Anur, P., Lin, E. Y., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.02.009 · Cited by 920
Specification of tissue-resident macrophages during organogenesis
Mass, E., Ballesteros, I., Farlik, M., Halbritter, F., Günther, P., Crozet, L., Jacome-Galarza, C. E., Händler, K., Klughammer, J., Kobayashi, Y., et al. (2016) · Science · doi:10.1126/science.aaf4238 · Cited by 891
Chow, A., Lucas, D., Hidalgo, A., Méndez-Ferrer, S., Hashimoto, D., Scheiermann, C., Battista, M., Leboeuf, M., Prophete, C., van Rooijen, N., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101688 · Cited by 864
High-fat diet enhances stemness and tumorigenicity of intestinal progenitors
Beyaz, S., Mana, M. D., Roper, J., Kedrin, D., Saadatpour, A., Hong, S.-J., Bauer-Rowe, K. E., Xifaras, M. E., Akkad, A., Arias, E., et al. (2016) · Nature · doi:10.1038/nature17173 · Cited by 845
Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation
Gagliani, N., Vesely, M. C. A., Iseppon, A., Brockmann, L., Xu, H., Palm, N. W., de Zoete, M. R., Licona-Limón, P., Paiva, R. S., Ching, T., et al. (2015) · Nature · doi:10.1038/nature14452 · Cited by 802
The role of myeloid cells in cancer therapies
Engblom, C., Pfirschke, C., & Pittet, M. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.54 · Cited by 788
White, M. C., Holman, D. M., Boehm, J. E., Peipins, L. A., Grossman, M., & Jane Henley, S. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.10.029 · Cited by 762
Clara, J. A., Monge, C., Yang, Y., & Takebe, N. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0293-2 · Cited by 752
Inflammatory memory sensitizes skin epithelial stem cells to tissue damage
Naik, S., Larsen, S. B., Gomez, N. C., Alaverdyan, K., Sendoel, A., Yuan, S., Polak, L., Kulukian, A., Chai, S., & Fuchs, E. (2017) · Nature · doi:10.1038/nature24271 · Cited by 745
The Colonic Crypt Protects Stem Cells from Microbiota-Derived Metabolites
Kaiko, G. E., Ryu, S. H., Koues, O. I., Collins, P. L., Solnica-Krezel, L., Pearce, E. J., Pearce, E. L., Oltz, E. M., & Stappenbeck, T. S. (2016) · Cell · doi:10.1016/j.cell.2016.05.018 · Cited by 733
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Wu, A., Wei, J., Kong, L.-Y., Wang, Y., Priebe, W., Qiao, W., Sawaya, R., & Heimberger, A. B. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq082 · Cited by 691
Regulatory T Cells in Skin Facilitate Epithelial Stem Cell Differentiation
Ali, N., Zirak, B., Rodriguez, R. S., Pauli, M. L., Truong, H.-A., Lai, K., Ahn, R., Corbin, K., Lowe, M. M., Scharschmidt, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.002 · Cited by 680
Wan, S., Zhao, E., Kryczek, I., Vatan, L., Sadovskaya, A., Ludema, G., Simeone, D. M., Zou, W., & Welling, T. H. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.039 · Cited by 675
Chang, A. L., Miska, J., Wainwright, D. A., Dey, M., Rivetta, C. V., Yu, D., Kanojia, D., Pituch, K. C., Qiao, J., Pytel, P., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0144 · Cited by 640
B cells, plasma cells and antibody repertoires in the tumour microenvironment
Sharonov, G. V., Serebrovskaya, E. O., Yuzhakova, D. V., Britanova, O. V., & Chudakov, D. M. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0257-x · Cited by 627
Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies
Bowman, R. L., Klemm, F., Akkari, L., Pyonteck, S. M., Sevenich, L., Quail, D. F., Dhara, S., Simpson, K., Gardner, E. E., Iacobuzio-Donahue, C. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.052 · Cited by 619
Sikic, B. I., Lakhani, N., Patnaik, A., Shah, S. A., Chandana, S. R., Rasco, D., Colevas, A. D., O’Rourke, T., Narayanan, S., Papadopoulos, K., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02018 · Cited by 599
T Helper Cell Cytokines Modulate Intestinal Stem Cell Renewal and Differentiation
Biton, M., Haber, A. L., Rogel, N., Burgin, G., Beyaz, S., Schnell, A., Ashenberg, O., Su, C.-W., Smillie, C., Shekhar, K., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.008 · Cited by 588
Sexual-dimorphism in human immune system aging
Márquez, E. J., Chung, C.-H., Marches, R., Rossi, R. J., Nehar-Belaid, D., Eroglu, A., Mellert, D. J., Kuchel, G. A., Banchereau, J., & Ucar, D. (2020) · Nature Communications · doi:10.1038/s41467-020-14396-9 · Cited by 584
Cancer stemness, intratumoral heterogeneity, and immune response across cancers
Miranda, A., Hamilton, P. T., Zhang, A. W., Pattnaik, S., Becht, E., Mezheyeuski, A., Bruun, J., Micke, P., de Reynies, A., & Nelson, B. H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818210116 · Cited by 576
The hallmarks of successful anticancer immunotherapy
Galluzzi, L., Chan, T. A., Kroemer, G., Wolchok, J. D., & López-Soto, A. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat7807 · Cited by 575
In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche
Fujisaki, J., Wu, J., Carlson, A. L., Silberstein, L., Putheti, P., Larocca, R., Gao, W., Saito, T. I., Celso, C. L., Tsuyuzaki, H., et al. (2011) · Nature · doi:10.1038/nature10160 · Cited by 567
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
Wang, G., Lu, X., Dey, P., Deng, P., Wu, C. C., Jiang, S., Fang, Z., Zhao, K., Konaparthi, R., Hua, S., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0224 · Cited by 553
Targeting Cancer Stemness in the Clinic: From Hype to Hope
Saygin, C., Matei, D., Majeti, R., Reizes, O., & Lathia, J. D. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.11.017 · Cited by 517
Self-citationInflammatory Links Between High Fat Diets and Diseases
Duan, Y., Zeng, L., Zheng, C., Song, B., Li, F., Kong, X., & Xu, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02649 · Cited by 495
Jinushi, M., Chiba, S., Yoshiyama, H., Masutomi, K., Kinoshita, I., Dosaka-Akita, H., Yagita, H., Takaoka, A., & Tahara, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106645108 · Cited by 479
Wainwright, D. A., Balyasnikova, I. V., Chang, A. L., Ahmed, A. U., Moon, K.-S., Auffinger, B., Tobias, A. L., Han, Y., & Lesniak, M. S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2130 · Cited by 472
A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages
Lu, H., Clauser, K. R., Tam, W. L., Fröse, J., Ye, X., Eaton, E. N., Reinhardt, F., Donnenberg, V. S., Bhargava, R., Carr, S. A., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3041 · Cited by 459
Fan, Q.-M., Jing, Y.-Y., Yu, G.-F., Kou, X.-R., Ye, F., Gao, L., Li, R., Zhao, Q.-D., Yang, Y., Lu, Z.-H., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.05.008 · Cited by 458
STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
Hsu, J.-M., Xia, W., Hsu, Y.-H., Chan, L.-C., Yu, W.-H., Cha, J.-H., Chen, C.-T., Liao, H.-W., Kuo, C.-W., Khoo, K.-H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04313-6 · Cited by 434
Cui, T. X., Kryczek, I., Zhao, L., Zhao, E., Kuick, R., Roh, M. H., Vatan, L., Szeliga, W., Mao, Y., Thomas, D. G., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.025 · Cited by 427
Sharma, M. D., Hou, D.-Y., Liu, Y., Koni, P. A., Metz, R., Chandler, P., Mellor, A. L., He, Y., & Munn, D. H. (2009) · Blood · doi:10.1182/blood-2008-12-195354 · Cited by 409
Quiescence Modulates Stem Cell Maintenance and Regenerative Capacity in the Aging Brain
Kalamakis, G., Brüne, D., Ravichandran, S., Bolz, J., Fan, W., Ziebell, F., Stiehl, T., Catalá-Martinez, F., Kupke, J., Zhao, S., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.040 · Cited by 399
Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
Paczulla, A. M., Rothfelder, K., Raffel, S., Konantz, M., Steinbacher, J., Wang, H., Tandler, C., Mbarga, M., Schaefer, T., Falcone, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1410-1 · Cited by 391
Ouzounova, M., Lee, E., Piranlioglu, R., El Andaloussi, A., Kolhe, R., Demirci, M. F., Marasco, D., Asm, I., Chadli, A., Hassan, K. A., et al. (2017) · Nature Communications · doi:10.1038/ncomms14979 · Cited by 379
Clocchiatti, A., Cora, E., Zhang, Y., & Dotto, G. P. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.30 · Cited by 374
CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer
Wang, D., Sun, H., Wei, J., Cen, B., & DuBois, R. N. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3199 · Cited by 356
Lechner, M. G., Karimi, S. S., Barry-Holson, K., Angell, T. E., Murphy, K. A., Church, C. H., Ohlfest, J. R., Hu, P., & Epstein, A. L. (2013) · Journal of Immunotherapy · doi:10.1097/01.cji.0000436722.46675.4a · Cited by 350
Gabrusiewicz, K., Li, X., Wei, J., Hashimoto, Y., Marisetty, A. L., Ott, M., Wang, F., Hawke, D., Yu, J., Healy, L. M., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1412909 · Cited by 348
Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients
Di Tomaso, T., Mazzoleni, S., Wang, E., Sovena, G., Clavenna, D., Franzin, A., Mortini, P., Ferrone, S., Doglioni, C., Marincola, F. M., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2730 · Cited by 344
Shi, Y., Ping, Y.-F., Zhou, W., He, Z.-C., Chen, C., Bian, B.-S.-J., Zhang, L., Chen, L., Lan, X., Zhang, X.-C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15080 · Cited by 344
Stem Cell Lineage Infidelity Drives Wound Repair and Cancer
Ge, Y., Gomez, N. C., Adam, R. C., Nikolova, M., Yang, H., Verma, A., Lu, C. P.-J., Polak, L., Yuan, S., Elemento, O., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.042 · Cited by 343
Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells
Zhou, J., Nefedova, Y., Lei, A., & Gabrilovich, D. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2017.12.004 · Cited by 339
IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation
Li, Y., Wang, L., Pappan, L., Galliher-Beckley, A., & Shi, J. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-87 · Cited by 319
Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry
Huang, Y.-K., Wang, M., Sun, Y., Di Costanzo, N., Mitchell, C., Achuthan, A., Hamilton, J. A., Busuttil, R. A., & Boussioutas, A. (2019) · Nature Communications · doi:10.1038/s41467-019-11788-4 · Cited by 301
Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells
Miao, Y., Yang, H., Levorse, J., Yuan, S., Polak, L., Sribour, M., Singh, B., Rosenblum, M. D., & Fuchs, E. (2019) · Cell · doi:10.1016/j.cell.2019.03.025 · Cited by 299
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment
Bocci, F., Gearhart-Serna, L., Boareto, M., Ribeiro, M., Ben-Jacob, E., Devi, G. R., Levine, H., Onuchic, J. N., & Jolly, M. K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815345116 · Cited by 299
Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells
Schatton, T., Schütte, U., Frank, N. Y., Zhan, Q., Hoerning, A., Robles, S. C., Zhou, J., Hodi, F. S., Spagnoli, G. C., Murphy, G. F., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1592 · Cited by 287
Single tumor-initiating cells evade immune clearance by recruiting type II macrophages
Guo, X., Zhao, Y., Yan, H., Yang, Y., Shen, S., Dai, X., Ji, X., Ji, F., Gong, X.-G., Li, L., et al. (2017) · Genes & Development · doi:10.1101/gad.294348.116 · Cited by 285
Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling
Fillmore, C. M., Gupta, P. B., Rudnick, J. A., Caballero, S., Keller, P. J., Lander, E. S., & Kuperwasser, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007863107 · Cited by 283
Wei, J., Barr, J., Kong, L.-Y., Wang, Y., Wu, A., Sharma, A. K., Gumin, J., Henry, V., Colman, H., Priebe, W., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0734 · Cited by 282
Peng, D., Tanikawa, T., Li, W., Zhao, L., Vatan, L., Szeliga, W., Wan, S., Wei, S., Wang, Y., Liu, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2528 · Cited by 274
Clinical development of therapies targeting TGFβ: current knowledge and future perspectives
Ciardiello, D., Elez, E., Tabernero, J., & Seoane, J. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.07.009 · Cited by 265
Tallerico, R., Todaro, M., Di Franco, S., Maccalli, C., Garofalo, C., Sottile, R., Palmieri, C., Tirinato, L., Pangigadde, P. N., La Rocca, R., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201542 · Cited by 251
Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma
Hutter, G., Theruvath, J., Graef, C. M., Zhang, M., Schoen, M. K., Manz, E. M., Bennett, M. L., Olson, A., Azad, T. D., Sinha, R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721434116 · Cited by 249
Pellegatta, S., Poliani, P. L., Corno, D., Menghi, F., Ghielmetti, F., Suarez-Merino, B., Caldera, V., Nava, S., Ravanini, M., Facchetti, F., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2048 · Cited by 248
Two to Tango: Dialog between Immunity and Stem Cells in Health and Disease
Naik, S., Larsen, S. B., Cowley, C. J., & Fuchs, E. (2018) · Cell · doi:10.1016/j.cell.2018.08.071 · Cited by 248
Hirata, Y., Furuhashi, K., Ishii, H., Li, H. W., Pinho, S., Ding, L., Robson, S. C., Frenette, P. S., & Fujisaki, J. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.01.017 · Cited by 247
Organ-Level Quorum Sensing Directs Regeneration in Hair Stem Cell Populations
Chen, C.-C., Wang, L., Plikus, M. V., Jiang, T. X., Murray, P. J., Ramos, R., Guerrero-Juarez, C. F., Hughes, M. W., Lee, O. K., Shi, S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.02.016 · Cited by 246
Otvos, B., Silver, D. J., Mulkearns-Hubert, E. E., Alvarado, A. G., Turaga, S. M., Sorensen, M. D., Rayman, P., Flavahan, W. A., Hale, J. S., Stoltz, K., et al. (2016) · Stem Cells · doi:10.1002/stem.2393 · Cited by 245
Self-citationMyeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner
Bayik, D., Zhou, Y., Park, C., Hong, C., Vail, D., Silver, D. J., Lauko, A., Roversi, G., Watson, D. C., Lo, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1355 · Cited by 245
Self-citationQuiescent tissue stem cells evade immune surveillance
Agudo, J., Park, E. S., Rose, S. A., Alibo, E., Sweeney, R., Dhainaut, M., Kobayashi, K. S., Sachidanandam, R., Baccarini, A., Merad, M., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.02.001 · Cited by 244
Su, W., Han, H. H., Wang, Y., Zhang, B., Zhou, B., Cheng, Y., Rumandla, A., Gurrapu, S., Chakraborty, G., Su, J., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.06.009 · Cited by 242
Ontogeny of Tumor-Associated Macrophages
Laviron, M., & Boissonnas, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01799 · Cited by 239
Transforming growth factor β as regulator of cancer stemness and metastasis
Bellomo, C., Caja, L., & Moustakas, A. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.255 · Cited by 235
Raghavan, S., Mehta, P., Xie, Y., Lei, Y. L., & Mehta, G. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0666-1 · Cited by 234
Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
Cioffi, M., Trabulo, S., Hidalgo, M., Costello, E., Greenhalf, W., Erkan, M., Kleeff, J., Sainz, B., & Heeschen, C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1399 · Cited by 229
Zhou, S., Yin, D., Hu, Z., Luo, C., Zhou, Z., Xin, H., Yang, X., Shi, Y., Wang, Z., Huang, X., et al. (2019) · Hepatology · doi:10.1002/hep.30630 · Cited by 226
Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity
Ning, N., Pan, Q., Zheng, F., Teitz-Tennenbaum, S., Egenti, M., Yet, J., Li, M., Ginestier, C., Wicha, M. S., Moyer, J. S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1400 · Cited by 222
Lee, Y., Shin, J. H., Longmire, M., Wang, H., Kohrt, H. E., Chang, H. Y., & Sunwoo, J. B. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2665 · Cited by 219
Svoronos, N., Perales-Puchalt, A., Allegrezza, M. J., Rutkowski, M. R., Payne, K. K., Tesone, A. J., Nguyen, J. M., Curiel, T. J., Cadungog, M. G., Singhal, S., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0502 · Cited by 217
Panni, R. Z., Sanford, D. E., Belt, B. A., Mitchem, J. B., Worley, L. A., Goetz, B. D., Mukherjee, P., Wang-Gillam, A., Link, D. C., DeNardo, D. G., et al. (2014) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-014-1527-x · Cited by 214
Lee, T. K.-W., Cheung, V. C.-H., Lu, P., Lau, E. Y. T., Ma, S., Tang, K. H., Tong, M., Lo, J., & Ng, I. O. L. (2014) · Hepatology · doi:10.1002/hep.27070 · Cited by 213
Wang, Y., Yin, K., Tian, J., Xia, X., Ma, J., Tang, X., Xu, H., & Wang, S. (2019) · Advanced Science · doi:10.1002/advs.201901278 · Cited by 211
The role of CSF1R-dependent macrophages in control of the intestinal stem-cell niche
Sehgal, A., Donaldson, D. S., Pridans, C., Sauter, K. A., Hume, D. A., & Mabbott, N. A. (2018) · Nature Communications · doi:10.1038/s41467-018-03638-6 · Cited by 206
Liang, S., Ristich, V., Arase, H., Dausset, J., Carosella, E. D., & Horuzsko, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803341105 · Cited by 202
Luo, Y., Chen, G.-L., Hannemann, N., Ipseiz, N., Krönke, G., Bäuerle, T., Munos, L., Wirtz, S., Schett, G., & Bozec, A. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.020 · Cited by 198
Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal niche
Chakrabarti, R., Celià-Terrassa, T., Kumar, S., Hang, X., Wei, Y., Choudhury, A., Hwang, J., Peng, J., Nixon, B., Grady, J. J., et al. (2018) · Science · doi:10.1126/science.aan4153 · Cited by 195
Yao, Y., Ye, H., Qi, Z., Mo, L., Yue, Q., Baral, A., Hoon, D. S. B., Vera, J. C., Heiss, J. D., Chen, C. C., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0858 · Cited by 188
Wang, D., Prager, B. C., Gimple, R. C., Aguilar, B., Alizadeh, D., Tang, H., Lv, D., Starr, R., Brito, A., Wu, Q., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1243 · Cited by 183
IL-22 is related to development of human colon cancer by activation of STAT3
Jiang, R., Wang, H., Deng, L., Hou, J., Shi, R., Yao, M., Gao, Y., Yao, A., Wang, X., Yu, L., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-59 · Cited by 182
Glioma-initiating cells: A predominant role in microglia/macrophages tropism to glioma
Liang, Y., Xiao, H., Xu, M., Ye, X.-Z., Hu, J., Li, F., Li, M., Luo, C., Yu, S., Bian, X., et al. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.011 · Cited by 172
Raggi, C., Correnti, M., Sica, A., Andersen, J. B., Cardinale, V., Alvaro, D., Chiorino, G., Forti, E., Glaser, S., Alpini, G., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.012 · Cited by 172
The NF-κB/AKT-dependent Induction of Wnt Signaling in Colon Cancer Cells by Macrophages and IL-1β
Kaler, P., Godasi, B. N., Augenlicht, L. H., & Klampfer, L. (2009) · Cancer Microenvironment · doi:10.1007/s12307-009-0030-y · Cited by 166
Ban, Y., Mai, J., Li, X., Mitchell-Flack, M., Zhang, T., Zhang, L., Chouchane, L., Ferrari, M., Shen, H., & Ma, X. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2913 · Cited by 166
Domenis, R., Cesselli, D., Toffoletto, B., Bourkoula, E., Caponnetto, F., Manini, I., Beltrami, A. P., Ius, T., Skrap, M., Di Loreto, C., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0169932 · Cited by 165
Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma
Tao, W., Chu, C., Zhou, W., Huang, Z., Zhai, K., Fang, X., Huang, Q., Zhang, A., Wang, X., Yu, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16827-z · Cited by 162
Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males
Sun, T., Warrington, N. M., Luo, J., Brooks, M. D., Dahiya, S., Snyder, S. C., Sengupta, R., & Rubin, J. B. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71048 · Cited by 161
Generali, D., Bates, G., Berruti, A., Brizzi, M. P., Campo, L., Bonardi, S., Bersiga, A., Allevi, G., Milani, M., Aguggini, S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1507 · Cited by 160
Ai, L., Mu, S., Sun, C., Fan, F., Yan, H., Qin, Y., Cui, G., Wang, Y., Guo, T., Mei, H., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1011-5 · Cited by 160
Alban, T. J., Bayik, D., Otvos, B., Rabljenovic, A., Leng, L., Jia-Shiun, L., Roversi, G., Lauko, A., Momin, A. A., Mohammadi, A. M., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01191 · Cited by 159
Self-citationZhang, Y., Zoltan, M., Riquelme, E., Xu, H., Sahin, I., Castro-Pando, S., Montiel, M. F., Chang, K., Jiang, Z., Ling, J., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.03.041 · Cited by 155
Sun, Y. H., Wang, Y., Fan, C., Gao, P., Wang, X., Wei, G., & Wei, J. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-137 · Cited by 153
Grange, C., Tapparo, M., Tritta, S., Deregibus, M. C., Battaglia, A., Gontero, P., Frea, B., & Camussi, G. (2015) · BMC Cancer · doi:10.1186/s12885-015-2025-z · Cited by 141
Foxp3+IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer
Yang, S., Wang, B., Guan, C., Wu, B., Cai, C., Wang, M., Zhang, B., Liu, T., & Yang, P. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0910506 · Cited by 139
Theocharides, A. P. A., Jin, L., Cheng, P.-Y., Prasolava, T. K., Malko, A. V., Ho, J. M., Poeppl, A. G., van Rooijen, N., Minden, M. D., Danska, J. S., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120502 · Cited by 137
Tenascin-C Protects Cancer Stem–like Cells from Immune Surveillance by Arresting T-cell Activation
Jachetti, E., Caputo, S., Mazzoleni, S., Brambillasca, C. S., Parigi, S. M., Grioni, M., Piras, I. S., Restuccia, U., Calcinotto, A., Freschi, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2346 · Cited by 135
Kenkel, J. A., Tseng, W. W., Davidson, M. G., Tolentino, L. L., Choi, O., Bhattacharya, N., Seeley, E. S., Winer, D. A., Reticker-Flynn, N. E., & Engleman, E. G. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2212 · Cited by 132
Hide, T., Komohara, Y., Miyasato, Y., Nakamura, H., Makino, K., Takeya, M., Kuratsu, J., Mukasa, A., & Yano, S. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.02.024 · Cited by 132
Brain tumor-initiating cells export tenascin-C associated with exosomes to suppress T cell activity
Mirzaei, R., Sarkar, S., Dzikowski, L., Rawji, K. S., Khan, L., Faissner, A., Bose, P., & Yong, V. W. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1478647 · Cited by 132
Nguyen, A., & Pollard, J. W. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0669 · Cited by 130
Li, X., Chen, C. Y., Xiang, D., Qu, L., Sun, W. C., Lu, X., Zhou, T., Chen, S., Ning, B., Cheng, Z., et al. (2017) · Hepatology · doi:10.1002/hep.29372 · Cited by 129
Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells
Morrison, B. J., Steel, J. C., & Morris, J. C. (2018) · BMC Cancer · doi:10.1186/s12885-018-4389-3 · Cited by 127
Nakano, M., Kikushige, Y., Miyawaki, K., Kunisaki, Y., Mizuno, S., Takenaka, K., Tamura, S., Okumura, Y., Ito, M., Ariyama, H., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0480-0 · Cited by 125
Resident macrophages influence stem cell activity in the mammary gland
Gyorki, D. E., Asselin-Labat, M.-L., van Rooijen, N., Lindeman, G. J., & Visvader, J. E. (2009) · Breast Cancer Research · doi:10.1186/bcr2353 · Cited by 122
Volonté, A., Di Tomaso, T., Spinelli, M., Todaro, M., Sanvito, F., Albarello, L., Bissolati, M., Ghirardelli, L., Orsenigo, E., Ferrone, S., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301342 · Cited by 118
Sox2 Communicates with Tregs Through CCL1 to Promote the Stemness Property of Breast Cancer Cells
Xu, Y., Dong, X., Qi, P., Ye, Y., Shen, W., Leng, L., Wang, L., Li, X., Luo, X., Chen, Y., et al. (2017) · Stem Cells · doi:10.1002/stem.2720 · Cited by 113
Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?
Martin, F., Apétoh, L., & Ghiringhelli, F. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.09.007 · Cited by 111
Increased PD ‐L1 expression in breast and colon cancer stem cells
Wu, Y., Chen, M., Wu, P., Chen, C., Xu, Z. P., & Gu, W. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12732 · Cited by 111
IL22RA1/STAT3 Signaling Promotes Stemness and Tumorigenicity in Pancreatic Cancer
He, W., Wu, J., Shi, J., Huo, Y., Dai, W., Geng, J., Lu, P., Yang, M., Fang, Y., Wang, W., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3131 · Cited by 110
Guo, X., Pan, Y., & Gutmann, D. H. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz080 · Cited by 106
Hsu, Y., Chen, Y., Chang, W., Jian, S., Fan, H.-L., Wang, J., & Kuo, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082427 · Cited by 97
Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
Liu, L., Zhang, L., Yang, L., Li, H., Li, R., Yu, J., Yang, L., Wei, F., Yan, C., Sun, Q., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00404 · Cited by 96
You, Y., Li, Y., Li, M., Lei, M., Wu, M., Qu, Y., Yuan, Y., Chen, T., & Jiang, H. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.13044 · Cited by 96
Barilla, R., Diskin, B. E., Caso, R. C., Lee, K. B., Mohan, N., Buttar, C., Adam, S., Sekendiz, Z., Wang, J., Salas, R. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09416-2 · Cited by 85
Towards a classification of stem cells
Laplane, L., & Solary, É. (2019) · eLife · doi:10.7554/elife.46563 · Cited by 84
Deciphering the Roles of Innate Lymphoid Cells in Cancer
Bruchard, M., & Ghiringhelli, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00656 · Cited by 79
Zhi, Y., Mou, Z., Chen, J., He, Y., Dong, H. F., Fu, X., & Wu, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135528 · Cited by 74
Shidal, C., Singh, N. P., Nagarkatti, P. S., & Nagarkatti, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2659 · Cited by 72
Yamashina, T., Baghdadi, M., Yoneda, A., Kinoshita, I., Suzu, S., Dosaka-Akita, H., & Jinushi, M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2169 · Cited by 71
Zhang, B., Ye, H., Ren, X., Zheng, S., Zhou, Q., Chen, C., Lin, Q., Li, G., Wei, L., Fu, Z., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.06.005 · Cited by 71
Eruslanov, E. B., Stoffs, T., Kim, W.-J., Daurkin, I., Gilbert, S. M., Su, L., Vieweg, J., Daaka, Y., & Kusmartsev, S. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2091 · Cited by 64
Lee, C., Das, B., Lin, T. L., Grimes, C., Zhang, X., Lavezzi, T., Huang, L., COLE, J. T., Yau, L. C., & Li, L. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09123.x · Cited by 58
Nomura, A., Gupta, V. K., Dauer, P., Sharma, N., Dudeja, V., Merchant, N. B., Saluja, A. K., & Banerjee, S. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0221 · Cited by 57
Wang, R., Yang, L., Zhang, C., Wang, R., Zhang, Z., He, Q., Chen, X., Zhang, B., Qin, Z., Wang, L., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1461303 · Cited by 44
Stein, R. G., Ebert, S., Schlahsa, L., Scholz, C. J., Braun, M., Hauck, P., Horn, E., Monoranu, C., Thiemann, V., Wustrow, M. P., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-0387 · Cited by 44
Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells
Ozawa, Y., Yamamuro, S., Sano, E., Tatsuoka, J., Hanashima, Y., Yoshimura, S., Sumi, K., Hara, H., Nakayama, T., Suzuki, Y., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.148 · Cited by 37
Sarmiento-Castro, A., Caamaño‐Gutiérrez, E., Sims, A. H., Hull, N. J., James, M. I., Santiago-Gómez, A., Eyre, R., Clark, C. I., Brown, M. E., Brooks, M. D., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.06.020 · Cited by 36
Indoleamine-2,3-dioxygenase elevated in tumor-initiating cells is suppressed by mitocans
Stapelberg, M., Zobalová, R., Nguyen, M. N., Walker, T., Stantic, M., Goodwin, J., Pasdar, E. A., Thai, T., Rohlenová, K., Yan, B., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.10.003 · Cited by 30
Cited by
Breast cancer: pathogenesis and treatments
Xiong, X., Zheng, L.-W., Ding, Y., Chen, Y.-F., Cai, Y.-W., Wang, L.-P., Huang, L., Liu, C.-C., Shao, Z.-M., & Yu, K.-D. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02108-4 · Cited by 958
Wang, S., Wang, J., Chen, Z., Luo, J., Guo, W., Sun, L., & Lin, L. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00522-z · Cited by 569
The hallmarks of cancer immune evasion
Galassi, C., Chan, T. A., Vitale, I., & Galluzzi, L. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.09.010 · Cited by 565
Chen, B., Yu, P., Chan, W. N., Xie, F., Zhang, Y., Liang, L., Leung, K. T., Lo, K. W., Yu, J., Tse, G. M. K., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01679-y · Cited by 420
Tumor-associated macrophages: an effective player of the tumor microenvironment
Basak, U., Sarkar, T., Mukherjee, S., Chakraborty, S., Dutta, A., Dutta, S., Nayak, D., Kaushik, S., Das, T., & Sa, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1295257 · Cited by 333
Metadata
- Authors
- Bayik, D., & Lathia, J. D.
- Venue
- Nature Reviews Cancer
- Published
- 2021-06-08
- Volume
- 21
- Issue
- 8
- Pages
- 526-536
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W3172039897
- Cited by
- 561
- References
- 156
- FWCI
- 14.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.